Man Group plc - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
Man Group plc ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$26,423,000
+275.8%
310,752
+56.6%
0.10%
+197.1%
Q2 2020$7,032,000
+2420.4%
198,432
+860.6%
0.04%
+1650.0%
Q1 2020$279,000
-77.3%
20,658
-67.7%
0.00%
-60.0%
Q1 2019$1,229,000
-71.1%
63,974
-78.6%
0.01%
-73.7%
Q4 2018$4,256,000
+0.5%
298,249
+46.8%
0.02%
+26.7%
Q3 2018$4,233,000
+49.0%
203,230
+69.4%
0.02%
+25.0%
Q2 2018$2,841,000120,0000.01%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders